Measuring Therapeutic Response in Chronic Graft-versus-host-disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus- Host Disease: Iv. Response Criteria Working Group Report
暂无分享,去创建一个
Daniel Wolff | Anita Lawitschka | Sandra A. Mitchell | Yoshihiro Inamoto | David A. Jacobsohn | J. Pidala | Stephanie J. Lee | F. Dignan | M. Flowers | S. Mitchell | Paul J. Martin | S. Pavletic | K. Schultz | M. Jagasia | A. Lawitschka | C. Kitko | Donna Przepiorka | Carrie L. Kitko | John Koreth | Madan Jagasia | Joseph Pidala | Attilio Olivieri | Iskra Pusic | Fiona L. Dignan | Anne M. Hall | Mary E.D. Flowers | Kirk R. Schultz | Georgia Boyce Vogelsang | Steven Z. Pavletic | D. Jacobsohn | G. Vogelsang | D. Wolff | D. Przepiorka | I. Pusic | Y. Inamoto | J. Koreth | A. Olivieri | A. Hall | P. Martin | Avivi | Avraham S Koren-Michowitz | Vera-Llonch | M. Oster | Hagiwara M
[1] S. Mineishi,et al. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] V. Mathiowetz,et al. Grip and pinch strength: norms for 6- to 19-year-olds. , 1986, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.
[3] S. Sonis,et al. Antimicrobial therapy to prevent or treat oral mucositis. , 2003, The Lancet. Infectious diseases.
[4] P. Campregher,et al. Lung function and long-term complications after allogeneic hematopoietic cell transplant. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] S. Elad,et al. A randomized controlled trial of visible-light therapy for the prevention of oral mucositis. , 2011, Oral oncology.
[6] M. Turner,et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] Y. Jen,et al. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. , 2012, International Journal of Radiation Oncology, Biology, Physics.
[8] B. Mohanti,et al. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. , 2012, European journal of cancer.
[9] J. Wright,et al. Measurement properties of the activities scale for kids. , 2000, Journal of clinical epidemiology.
[10] M. Nagashima,et al. The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. epidemiology of DMARDs treatment in Japan. , 2005, Clinical and experimental rheumatology.
[11] C. Barber,et al. Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis , 2007, Supportive Care in Cancer.
[12] C. Cleeland,et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. , 2000, Cancer.
[13] H. Deeg,et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. , 2002, Blood.
[14] M. Vidyasagar,et al. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy—a randomized controlled trial , 2013, Supportive Care in Cancer.
[15] L. Matza,et al. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[16] J. Epstein,et al. Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy. , 2008, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[17] S. Piantadosi,et al. Development of a prognostic model for grading chronic graft-versus-host disease. , 2001, Blood.
[18] Li Li,et al. A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] P. Opolon,et al. Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection. , 2009, International journal of radiation oncology, biology, physics.
[20] M. Andrykowski,et al. Psychometric evaluation of the Pittsburgh Sleep Quality Index. , 1998, Journal of psychosomatic research.
[21] Jan-Jakob Sonke,et al. Clinical results of image-guided deep inspiration breath hold breast irradiation. , 2010, International journal of radiation oncology, biology, physics.
[22] John P Klein,et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. , 2002, Blood.
[23] Lisa I. Wang,et al. A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. , 2012, Journal of pain and symptom management.
[24] M. List,et al. The measurement of performance in childhood cancer patients , 1987, Cancer.
[25] B. Storer,et al. Clinical benefit of response in chronic graft-versus-host disease. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] B. Kurland,et al. Validation of measurement scales in ocular graft-versus-host disease. , 2012, Ophthalmology.
[27] V. Falanga,et al. Use of a durometer to assess skin hardness. , 1993, Journal of the American Academy of Dermatology.
[28] A. Huscher,et al. Transdermal buprenorphine for oropharyngeal mucositis-associated pain in patients treated with radiotherapy for head and neck cancer. , 2010, Journal of palliative medicine.
[29] A. Bonomi,et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale , 1997, Bone Marrow Transplantation.
[30] J. Varni,et al. Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL Stem Cell Transplant module and results of a pilot study , 2014, Bone Marrow Transplantation.
[31] G. Browman,et al. Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials. , 2001, International journal of radiation oncology, biology, physics.
[32] J. Pidala,et al. Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[33] J J Anderson,et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[34] B. Kurland,et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. , 2011, Blood.
[35] P. Lachenbruch,et al. Defining Clinical Improvement in Adult and Juvenile Myositis. , 2003, The Journal of rheumatology.
[36] T. Braun,et al. Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[37] Ingela Wiklund,et al. Assessment of patient‐reported outcomes in clinical trials: the example of health‐related quality of life , 2004, Fundamental & clinical pharmacology.
[38] K. Stevenson,et al. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[39] G. Norman,et al. Is it simple or simplistic? , 2003, Medical care.
[40] N. Facione,et al. Radiation-Induced Mucositis: A Randomized Clinical Trial of Micronized Sucralfate Versus Salt & Soda Mouthwashes , 2003, Cancer investigation.
[41] A. Bacigalupo,et al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. , 2003, Haematologica.
[42] B. Storer,et al. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. , 2003, Blood.
[43] A. Lammers,et al. The 6-minute walk test: normal values for children of 4–11 years of age , 2007, Archives of Disease in Childhood.
[44] M. Levitt,et al. Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[45] A. Brugnera,et al. Use of 660-nm diode laser in the prevention and treatment of human oral mucositis induced by radiotherapy and chemotherapy. , 2010, Photomedicine and laser surgery.
[46] V. Darcourt,et al. Low-energy He/Ne laser in the prevention of radiation-induced mucositis , 1999, Supportive Care in Cancer.
[47] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[48] D. Brooks,et al. The two-minute walk test as a measure of functional capacity in cardiac surgery patients. , 2004, Archives of physical medicine and rehabilitation.
[49] P. Herzberg,et al. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center , 2013, Bone Marrow Transplantation.
[50] D. Kleiner,et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[51] D. Sackett,et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.
[52] S. Clarke,et al. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] R. Fanin,et al. Treatment of refractory chronic GVHD with rituximab: a GITMO study , 2007, Bone Marrow Transplantation.
[54] C. Bombardier,et al. The role of children in reporting their physical disability. , 1995, Archives of physical medicine and rehabilitation.
[55] J. Epstein,et al. Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. , 2001, Oral oncology.
[56] C. Doré,et al. Reliability, repeatability and sensitivity to change of externally and self-paced walking tests in COPD patients. , 2003, Respiratory medicine.
[57] W. Bailey,et al. Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .
[58] G. Baker,et al. A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment , 2003, Journal of neurology, neurosurgery, and psychiatry.
[59] P. Stratton,et al. Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. , 2012, Seminars in hematology.
[60] D. Au,et al. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. , 2005, American journal of respiratory and critical care medicine.
[61] R. Schiffman,et al. Reliability and validity of the Ocular Surface Disease Index. , 2000, Archives of ophthalmology.
[62] M. Petri,et al. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. , 2011, Arthritis and rheumatism.
[63] L. Chow,et al. Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients , 2010, Expert opinion on investigational drugs.
[64] J. V. Stone,et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. , 1999, The New England journal of medicine.
[65] John E. Ware,et al. SF-36 Health Survey Update , 2000, Spine.
[66] R. Portenoy,et al. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®) , 2001, Pain.
[67] W. Hauck,et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. , 1996, Oncology nursing forum.
[68] J. Varni,et al. The PedsQL: measurement model for the pediatric quality of life inventory. , 1999, Medical care.
[69] M. Paesmans,et al. The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies , 2008, Supportive Care in Cancer.
[70] S. Steinberg,et al. Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures , 2014, Bone Marrow Transplantation.
[71] J. Brazier,et al. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D , 2003, Health and quality of life outcomes.
[72] F. V. D. van den Hoogen,et al. Reliability of two methods to assess morphea: skin scoring and the use of a durometer. , 1997, Journal of the American Academy of Dermatology.
[73] D. Gossot,et al. The Spectrum of Lung Involvement in Collagen Vascular-Like Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation: Report of 6 Cases and Review of the Literature , 2011, Medicine.
[74] Rabia S. Atayee,et al. Ketamine mouthwash for mucositis pain. , 2009, Journal of palliative medicine.
[75] D. Osoba,et al. Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] N. Leidy,et al. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[77] S. Steinberg,et al. NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD , 2014, Bone Marrow Transplantation.
[78] J. Stockman,et al. Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer: A Randomized Trial , 2012 .
[79] A. Scherlacher,et al. [Radiotherapy of head-neck neoplasms: prevention of inflammation of the mucosa by sucralfate treatment]. , 1990, HNO.
[80] D. Weisdorf,et al. Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation. , 2005, Blood.
[81] C. Cleeland,et al. Assessing symptom distress in cancer patients , 2000 .
[82] J. Bijlsma,et al. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment. , 2012, Autoimmunity reviews.
[83] N. Bae,et al. Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation. , 2005, Transplantation proceedings.
[84] I. Barofsky,et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States , 2004, Quality of Life Research.
[85] V. Mathiowetz,et al. Grip and pinch strength: normative data for adults. , 1985, Archives of physical medicine and rehabilitation.
[86] D. Jacobsohn,et al. Weight loss and malnutrition in patients with chronic graft-versus-host disease , 2002, Bone Marrow Transplantation.
[87] J. Lai,et al. Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study , 2014, Supportive Care in Cancer.
[88] D. Maloney,et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation , 2006, Bone Marrow Transplantation.
[89] I. Braverman,et al. Reproducible measurements to quantify cutaneous involvement in scleroderma. , 1995, Archives of dermatology.
[90] S. Pavletic,et al. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. , 2013, Oral diseases.
[91] G. Vogelsang,et al. Chronic graft versus host disease , 2004, British journal of haematology.
[92] T. Therneau,et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[93] B. Kurland,et al. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium. , 2012, Blood.
[94] N. Young,et al. Activities Scale for Kids: An Analysis of Normals , 2003, Journal of pediatric orthopedics.
[95] J J Anderson,et al. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. , 2001, Arthritis and rheumatism.
[96] Q. Le,et al. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[97] R. Waters,et al. Energy‐speed relationship of walking: Standard tables , 1988, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[98] G. Donaldson,et al. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation development of an oral mucositis index , 1992, Cancer.
[99] J. Shelhamer,et al. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[100] M. Liang,et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.
[101] W. Wood,et al. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[102] N. Leidy,et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD) , 2010, Bone Marrow Transplantation.
[103] H. So,et al. The six-minute walk test in healthy children: reliability and validity , 2005, European Respiratory Journal.
[104] N. Chu. Effect of levodopa treatment for parkinsonism in welders: A double-blind study , 2004, Neurology.
[105] R. Storb,et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. , 2004, Blood.
[106] J. Atkinson,et al. Chronic graft versus host disease of oral mucosa: review of available therapies. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[107] A. Bron,et al. Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests , 2003, Cornea.
[108] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[109] G. Birgegard,et al. Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy—a randomized controlled trial , 2007, Supportive Care in Cancer.
[110] A. Eckardt,et al. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. , 2004, Oral oncology.
[111] S. Kaplan,et al. Preliminary psychometric evaluation of the Child Health Ratings Inventory (CHRIs) and Disease-Specific Impairment Inventory-Hematopoietic Stem Cell Transplantation (DSII-HSCT) in parents and children , 2005, Quality of Life Research.
[112] E. Cook,et al. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[113] C. Kalofonos,et al. Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study. , 2007, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[114] F. Spijkervet,et al. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients , 1991, Journal of surgical oncology.
[115] A. Sevinç,et al. Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy - a randomized controlled trial. , 2012, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[116] G. Slade. Assessing change in quality of life using the Oral Health Impact Profile. , 1998, Community dentistry and oral epidemiology.
[117] E. Farmer,et al. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft‐vs.‐host disease , 2004, Photodermatology, photoimmunology & photomedicine.
[118] S. Kaplan,et al. Health‐related quality of life in pediatric bone marrow transplant survivors: According to whom? , 1999, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[119] L. Cerezo,et al. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[120] M. Vidyasagar,et al. Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients - a triple blinded randomized controlled trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[121] S. Svegliati,et al. Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD. , 2013, Blood.
[122] J. Atkinson,et al. Salivary hypofunction and xerostomia: diagnosis and treatment. , 2005, Dental clinics of North America.
[123] M. Denniston,et al. Measurement of fatigue in cancer patients: Further validation of the Fatigue Symptom Inventory , 2004, Quality of Life Research.
[124] A. Ghavamzadeh,et al. Effect of pilocarpine hydrochloride on unstimulated whole saliva flow rate and composition in patients with chronic graft-versus-host disease (cGVHD) , 2007, Bone Marrow Transplantation.
[125] M. Ward,et al. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. , 2000, The Journal of rheumatology.
[126] R. Childs,et al. Topical thalidomide gel in oral chronic GVHD and role of in situ cytokine expression in monitoring biological activity , 2013, Bone Marrow Transplantation.
[127] S. Elad,et al. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD). , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[128] D. Brizel,et al. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[129] D. Cowen,et al. Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. , 1997, International journal of radiation oncology, biology, physics.
[130] K. Dumford,et al. CT and MRI findings in sclerodermatous chronic graft vs. host disease. , 2001, Clinical imaging.
[131] Daniel J Buysse,et al. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.
[132] M. Turner,et al. Vulvovaginal Chronic Graft-Versus-Host Disease With Allogeneic Hematopoietic Stem Cell Transplantation , 2007, Obstetrics and gynecology.
[133] L. Nail,et al. Operationalizing symptom distress in adults with cancer: a literature synthesis. , 2005, Oncology nursing forum.
[134] K. Ohrn,et al. Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial. , 2010, Journal of clinical nursing.
[135] P. Rutgeerts,et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. , 2002, Gastroenterology.
[136] C. Basch,et al. Pediatric allo-SCT for malignant and non-malignant diseases: impact on health-related quality of life outcomes , 2013, Bone Marrow Transplantation.
[137] A. Balan,et al. Effectiveness of triclosan in the management of radiation-induced oral mucositis: a randomized clinical trial. , 2010, Journal of cancer research and therapeutics.
[138] J. Clayton,et al. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I) , 2013, Scientific Reports.
[139] B. Reeve,et al. Feasibility and Reproducibility of the New NIH Consensus Criteria To Evaluate Response in Chronic GvHD - A Pilot Study. , 2005 .
[140] R. Jonsson,et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.
[141] P. Herzberg,et al. Validation of the grip test and human activity profile for evaluation of physical performance during the intermediate phase after allogeneic hematopoietic stem cell transplantation , 2013, Supportive Care in Cancer.
[142] H. Greinix,et al. A single-center pilot validation study of a new chronic GVHD skin scoring system. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[143] A. Barrett,et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease , 2004, Bone Marrow Transplantation.
[144] J. Klein,et al. Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. , 2011, Blood.
[145] B. Sandmaier,et al. Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease. , 2013, Blood.
[146] P. Herzberg,et al. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[147] A. Colman,et al. Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences. , 2000, Acta psychologica.
[148] P. Robertson,et al. Absorption of Fentanyl from Fentanyl Buccal Tablet in Cancer Patients With or Without Oral Mucositis , 2007, Clinical drug investigation.
[149] M. Kerscher,et al. Chronic cutaneous sclerodermoid graft‐versus‐host disease: evaluation by 20‐MHz sonography , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.
[150] A. Borkhardt,et al. Oral graft vs. host disease in children – Treatment with topical tacrolimus ointment , 2007, Pediatric transplantation.
[151] R. Seshadri,et al. EOSINOPHILIA CORRELATES WITH THE PRESENCE OR DEVELOPMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN CHILDREN , 2004, Transplantation.
[152] S. Farag. Chronic graft-versus-host disease: where do we go from here? , 2004, Bone Marrow Transplantation.
[153] W. Bailey,et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. , 2000, American journal of respiratory and critical care medicine.
[154] S. Kaplan,et al. Maternal perspectives on children's health-related quality of life during the first year after pediatric hematopoietic stem cell transplant. , 2006, Journal of pediatric psychology.
[155] M. Vidyasagar,et al. Efficacy of He-Ne Laser in the prevention and treatment of radiotherapy-induced oral mucositis in oral cancer patients. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[156] J. Giordano,et al. Use of sublingual methadone for treating pain of chemotherapy-induced oral mucositis. , 2010, Journal of opioid management.
[157] A. Loeckinger,et al. Six-minute walk test in children and adolescents. , 2007, The Journal of pediatrics.
[158] S. Lopez,et al. Efficacy of gelclair in reducing pain in palliative care patients with oral lesions: preliminary findings from an open pilot study. , 2002, Journal of pain and symptom management.
[159] V. Mathiowetz,et al. Reliability and validity of grip and pinch strength evaluations. , 1984, The Journal of hand surgery.
[160] David T Felson,et al. UvA-DARE (Digital Academic Repository) American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials , 2011 .
[161] D. Madtes,et al. Pulmonary function testing prior to hematopoietic stem cell transplantation , 2005, Bone Marrow Transplantation.
[162] S. Steinberg,et al. Oral Chronic Graft-vs.-Host Disease Characterization Using the NIH Scale , 2012, Journal of dental research.
[163] Steven Hirschfeld,et al. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report , 2006 .
[164] L. Cerchietti,et al. Effect of topical morphine for mucositis‐associated pain following concomitant chemoradiotherapy for head and neck carcinoma , 2002, Cancer.
[165] Shao-xiong Wu,et al. A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[166] J. Sørensen,et al. Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies , 2008, Cancer.
[167] M. Levenstein,et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. , 1995, The Journal of infectious diseases.